Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pharm Sci. 2014 May;103(5):1315-30. doi: 10.1002/jps.23931. Epub 2014 Mar 12.

Impact of residual impurities and contaminants on protein stability.

Author information

  • 1Pfizer Inc, Chesterfield, Missouri, 63017.

Abstract

Production of recombinant proteins generates a variety of process-related impurities. The multistep manufacturing processes may introduce many potential contaminants into the final pharmaceutical products. These residual impurities and contaminants can potentially impact the protein stability significantly. In this short review, the authors intend to discuss major sources and types of residual process-related impurities and potential product contaminants, their impact on protein quality/stability, and possible mitigations during product development and manufacturing processes.

© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

KEYWORDS:

biotechnology; deamidation; formulation; oxidation; protein aggregation

PMID:
24623189
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk